This is the first study to investigate macular sO2 of glaucoma subjects using the retinal oximetry of dual-channel VIS-OCT. VIS-OCT uniquely allows scanning of the macular arterioles and venules to calculate macular sO2 without the confounding signals from other layers that plague traditional fundus-based oximetry.
RGCs are most abundant in macula, and that they are the major energy consumer in inner retina. Unmyelinated RGC axons up to the lamina cribrosa require significant amounts of energy to generate and propagate action potentials,
31 and RGC somata have high energy demand to actively synthesize transmitters, transport cargo, and maintain ion balance across cell membranes.
32 These tremendous energy needs are subserved by the dense mitochondria in RGC somas in the macular region and within the IPL where synapses are formed.
33,34 Our finding suggests that early RGC/RNFL loss may reduce the energy demand, which is manifested with reduction of oxygen extraction in the macular region, correlated with the thinning of GCL + IPL + RNFL.
We observe variations in sO
2 among different arterioles and venules in the same eyes. In normal retinas, the variability is more likely determined by the measurement accuracy, with the limited number of A-lines per branch. Both the spectral signal and algorithm can contribute to the measurement variation. Vessel averaging effectively reduces variability. Our previous study achieved a coefficient of variation (CV) < 3% within a single day and <5% across five weeks with ∼4× more A-lines per vessel than the current study.
35 For pathological eyes, the difference from individual branches may be also due to pathological changes. Nonetheless, the empirical vessel averaging within an eye or a hemisphere shows correlation between macular sO
2 markers with the severity of glaucoma. In any case, the improvements in imaging devices and algorithms will improve the accuracy of VIS-OCT macular oximetry, ultimately leading to better clinical utility.
We found macular sO2 is correlated with severity of glaucoma and performs better at separating GS/PPG from normal eyes than GCL+NFL and cpRNFL thinning. The declination of AsO2 in more severe stage of glaucoma is interesting, which could indicate pathological role of vascular function or merely a consequence of RGC loss and compromise of neurovascular coupling. Further studies are required to delineate the causal relationship. Within the PG group, AsO2 is significantly correlated with GCL + NFL and cpRNFL thicknesses, which is attributable by the more severely damaged lower hemifield. This correlation analysis strongly indicates that macular sO2 is associated with glaucomatous macular tissue loss. Importantly, macular VsO2 and A-V sO2 have significant differences when comparing normal with GS/PPG eyes, even before detectable thinning and visual field damage.
All existing literature regarding sO
2 in glaucoma reported global measurements from the major vessels in the parapapillary region around the ONH, which is difficult to extrapolate to macular sO
2 in this presented study.
36–43 Nonetheless, those reports showed rather consistent AsO
2 in major retinal arterioles, or in rare cases, higher AsO
2 in PG subjects. Although the inclusion criteria and subject population differ, those reports also showed decreased global A-V sO
2 in glaucoma, underlay by reduced metabolic demand with RGCs loss. Remarkably, we observed a similar reduction of A-V sO
2, as well as OE at a more localized macular region. Given that RGCs are most abundant in macula, and that they are the major energy consumer in inner retina, our finding suggests that early RGC/RNFL damage may be manifested with reduction of oxygen metabolism in the macular region, correlated with the thinning of GCL + IPL + RNFL. It is worth noting that, contrary to an unchanged (or slightly increased) global AsO
2 in previous reports,
37–43 we found that macular AsO
2 significantly declined with glaucoma severity among three groups. This difference is primarily due to the distinct measurement locations and methodologies.
Both AsO2 and A-V sO2 are significantly correlated with thicknesses of GCL + NFL and cpRNFL either among three groups or within PG eyes. In addition, in PG eyes, the correlation is primarily driven by the more severely damaged lower hemifield. To our surprise, we didn't find a significant correlation between VsO2 and GCL+NFL or cpRNFL, whether among three groups or within PG eyes. Upon closer examination of the data, VsO2 increases significantly from normal to GS/PPG, but remains relatively consistent between two more severer groups. We speculate that VsO2 is more significantly impacted in early stage of tissue atrophy in glaucoma, while the AsO2 continues to decline along with the progressing severity. A more comprehensive dataset including macular blood flow would further elucidate the speculation.
We found no significant correlation between global MD and any macular sO
2 parameters or GCL + IPL/cpRNFL. We note that 24-2 VFT only has four measurement points within a 25° center viewing angle in the macula, thus undersampling the macular region, which may lead to large variations.
16 Also, because the RGCs are highly redundant in macula up to 30% of RGC, loss can proceed to visual field damage.
10 Therefore, it is not totally surprising that correlations between MD and other variables are not statistically significant within this study population.
VIS-OCT holds significant promise for advancing glaucoma diagnostics and patient care. Beyond its ability to measure macular sO
2, which is key for early detection and monitoring of glaucoma, VIS-OCT can provide several other advantages. Its ultrahigh axial resolution allows for detailed visualization of retinal microstructures, particularly the sub-band changes in the outer retina.
44 Additionally, VIS-OCT can assess the reflectivity of RNFL, which correlates with glaucoma severity and provides another sensitive marker for early disease detection.
30 The technology also facilitates fibergraphy, allowing for the visualization and quantification of RGC axon bundles, which are essential for understanding disease progression.
45 These capabilities make VIS-OCT a comprehensive tool for not only diagnosing and monitoring glaucoma but also for potentially improving the overall management in clinical practice.
There were several limitations of this study that we would like to address in future studies. First, the cohort size was limited. A larger subject population would be beneficial for multivariable statistical analysis. Second, the implementation of visible light can cause discomfort to some subjects, and it is more susceptible to cataracts and aging eyes. To address this, we will further optimize the imaging device including eye tracking and automatic focusing, which will significantly reduce exposure to visible light. Third, the current data processing used manual segmentations for selecting vessel ROIs, as well as assignment of arterioles and venules based on experience. Potential bias and subjectivity can be introduced by manual segmentation and vessel assignment. To mitigate this issue, we standardized our approach for all subjects among three groups. This standardized approach helps to minimize bias and improve the reliability of our findings. Future studies will incorporate automated segmentation algorithms and vessel tracing to streamline the data processing, further reducing potential bias and enhance reproducibility. Finally, to balance the image depth range and signal to noise ratio, the device used in this study has a relatively short visible light bandwidth of 35 nm. Our new-generation VIS-OCT device improved the resolution with wider wavelength bands and expanded the working range.
46 With more precise extracted spectra, it will help increase the calculation accuracy of sO
2 in future studies.
In conclusion, we report the first study of VIS-OCT to investigate the macular sO2 in glaucoma subjects. With its high resolution in both axial and lateral directions, VIS-OCT is a powerful tool to characterize macular sO2 and identify the significant differences between normal, GS/PPG and PG subjects. The measurement of sO2 can potentially act as a marker to provide early diagnosis and monitor the progress of glaucoma disease.